Latest Regulatory Compliance News

Kingsgate Consolidated updates its 2025 Mineral Resources and Ore Reserves, introducing a maiden estimate for the Chatree South-East Complex while reporting modest declines in overall Ore Reserves.

MedAdvisor Limited will have its trading suspension lifted on 10 October 2025 following the lodgement of its annual financial report, marking a key moment for investors.

Nordic Resources Ltd attributes its recent share price and volume spike to a successful investor roadshow and capital raising tied to its new Finland gold projects, while confirming full ASX compliance.

Emu NL has agreed to delay issuing shortfall securities tied to its recent entitlement offer until late October, as the Takeovers Panel continues its review following a challenge by Dronkay Pty Ltd.

Ainsworth Game Technology’s CEO Harald Neumann faces a setback as the Nevada Gaming Control Board recommends withdrawing his license application, prompting a board review of his role.

Fiducian Group Limited has reported a robust 23% increase in net profit after tax for the year ended June 2025, driven by strong inflows and resilient performance across its financial planning, platform administration, and investment management segments despite challenging market conditions.

Netwealth Group Limited has reported a landmark quarter with total Funds Under Administration soaring to $120.8 billion, driven by record first-quarter net flows of $4.1 billion and strategic service expansions.

Guzman y Gomez reports robust Q1 FY26 sales growth and network expansion, alongside a significant $100 million share buyback to enhance shareholder value.

European Lithium Limited updates investors on the expiry of 208 million options and outlines plans for issuing replacement options pending shareholder approval.

BlackRock Investment Management (Australia) Limited has announced estimated cash distributions for a suite of Australian iShares ETFs, outlining key dates and options for reinvestment. Investors are reminded to complete necessary tax certifications ahead of the record date.

Imperial Pacific Limited has announced its Dividend Reinvestment Plan (DRP) issue price for 2025 at $1.85 per new share, maintaining parity with current trading levels and foregoing any discount. New shares will be issued within two weeks, aligning with existing shares.

Anatara Lifesciences has completed the first tranche of its two-part share placement, issuing over 33 million ordinary shares to professional investors. This move marks a significant step in the company’s capital raising efforts amid ongoing product development.